Viewing Study NCT00325156


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-01-02 @ 9:56 PM
Study NCT ID: NCT00325156
Status: COMPLETED
Last Update Posted: 2020-01-02
First Post: 2006-02-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants
Sponsor: GlaxoSmithKline
Organization: